Levetiracetam-induced platelet dysfunction

Epilepsy Research

Volumn 86, Issue 1, 2009, Pages 94-96

  Hacquard, Marie ^a,b   Richard, Sébastien ^a,b   Lacour, Jean Christophe ^a   Lecompte, Thomas ^a,b   Vespignani, Hervé ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Antiepileptic drug; Antiplatelet effect; Clopidogrel; Haemostasis; Levetiracetam

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ETIRACETAM; LAMOTRIGINE; PIRACETAM;

AGED; ANAMNESIS; ARTICLE; BLOOD CLOTTING; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOCAL EPILEPSY; HEMOSTASIS; HOSPITAL ADMISSION; HUMAN; MALE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION;

AGED; ANTICONVULSANTS; BLOOD PLATELET DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PIRACETAM; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SEIZURES; TICLOPIDINE;

EID: 68749105661     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2009.04.003     Document Type: Article

References (7)

1. Boon P., Hulhoven R., and Offner F. Levetiracetam and bleeding disorders. Acta Neurol. Belg. 107 (2007) 97-102
2. De Smedt T., Raedt R., Vonck K., et al. Levetiracetam: the profile of a novel anticonvulsant drug. Part I. Preclinical data. CNS Drug Rev. 13 (2007) 43-56
3. Kimland E., Höjeberg B., and von Euler M. Levetiracetam-induced thrombocytopenia. Epilepsia 45 (2004) 877-878
4. Kis B., Szupera Z., Mezei Z., et al. Valproate treatment and platelet function: the role of arachidonate metabolites. Epilepsia 40 (1999) 186-189
5. Meschede A., Runge U., and Sabolek M. Thrombocytopenia during levetiracetam therapy. Epilepsy Res. 80 (2008) 91-92
6. Moriau M., Crasborn L., Lavenne-Pardonge E., et al. Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects. Arzneimittelforschung 43 (1993) 110-118
7. Rüegg S., Naegelin Y., Hardmeier M., et al. Intravenous levetiracetam: treatment experience with the first 50 critically ill patients. Epilepsy Behav. 12 (2008) 477-480